AS

Anurag Saxena

Active Director Director DIN 08024144
DIN 08024144 First appointment Dec 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value •••• Premium profile

About Anurag Saxena

Data last updated:

Anurag Saxena is a Director at Doshafix Drugs Private Limited (since 2017). The company operates in Healthcare. Doshafix Drugs Private Limited reported revenue of ₹6.6 Lakh (FY 2017).

DIN 08024144
Primary Designation Director
Industry Healthcare
First Appointment 15 Dec 2017
Oldest Company Age 11 yrs
Largest company Doshafix Drugs Private Limited · ₹6.6 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Doshafix Drugs Private Limited U24233UP2015PTC072085
Director15 Dec 20172015₹6.6 Lakh (FY 2017)Active

Board colleagues of Anurag Saxena

NameDINCompanyDesignation
Abhinav Saxena08105382Doshafix Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Doshafix Drugs Private Limited
Premium access

Shareholding and investment profile for Anurag Saxena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anurag Saxena

Anurag Saxena currently holds 1 directorship: Doshafix Drugs Private Limited (Director, since 15 Dec 2017, revenue ₹6.6 Lakh (FY 2017)).

Anurag Saxena was first appointed on 15 Dec 2017 as Director at Doshafix Drugs Private Limited.

The current boards of Anurag Saxena's companies include Abhinav Saxena (Doshafix Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available